XBiotech competitorsClear all

Praxis Precision Medicines's top competitors include Aptinyx and RAPT Therapeutics.
Praxis Precision Medicines
Praxis Precision Medicines
Praxis Precision Medicines is a company that develops therapies intended for patients and families affected by complex and debilitating brain disorders.
Aptinyx
Aptinyx
Aptinyx is a clinical-stage biopharmaceutical company focused on the discovery and development of transformative therapies for challenging neurologic disorders.
RAPT Therapeutics
RAPT Therapeutics
RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents.
Founding Date
Founding Date
2015
Founding Date
2015
Founding Date
2015
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Locations
Evanston, US HQ
Evanston, US
Locations
South San Francisco, US HQ
Employees
Employees
50
Employees
635% increase
Employees
64
Valuation ($)
Valuation ($)
831.2 m
Valuation ($)
207.6 m
Valuation ($)
671.5 m
Employee Rating
Employee Rating
N/A
Employee Rating
3.5
Employee Rating
4.7

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$1.6m (FY, 2020)
Revenue (est.)
$5m (FY, 2020)
Net income
Net income
($61.8m) (FY, 2020)
Net income
($50.1m) (FY, 2020)
Net income
($52.9m) (FY, 2020)

Funding

Total funding raised
Total funding raised
$ 131.9m
Total funding raised
$ 135m
Total funding raised
$ 176m
For sources of this data, please see the company profile

View company profiles

Aptinyx
HQ
Evanston, US
Employees
63↑ 5% increase

Aptinyx is a clinical-stage biopharmaceutical company focused on the discovery and development of transformative therapies for challenging neurologic disorders.

View company
RAPT Therapeutics
HQ
South San Francisco, US
Employees
64

RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents.

View company